Eospace Inc.

Eospace Inc., a minority-owned, Asian-Pacific American-owned small business manufacturer based in Redmond, Washington, develops and manufactures advanced electro-optic integrated circuits, components, and modules for defense and scientific applications, competing as a prime contractor on 94% of its awards predominantly under total small business set-asides through SBIR and STTR programs.

Eospace specializes in lithium niobate modulators, phase modulators, electro-optic fiber-coupled modulators, and RF mixers designed for optical telecommunications, directed energy weapons, electronic warfare systems, and space-based sensors. The company's federal work splits heavily between research-phase contracts (SBIR Phase I and II, STTR Phase I and II) and production orders for specialized photonic components. Recent prime work includes a $10.5 million SBIR Phase III contract from the Missile Defense Agency (awarded September 2024) for high-efficiency phase modulators for high-energy laser systems, a $1.3 million STTR Phase II contract from Naval Air Warfare Center (May 2023) for research and development in electro-optic technologies, a $1.2 million SBIR Phase II contract from Naval Strategic Systems Programs (February 2025) for advanced photonic development, and a $199,949 purchase order from the Air Force Research Laboratory (August 2025) for low-cost manufacturing of thin-film niobate. Component orders typically range from $10,500 to $136,825 and target discrete items such as lithium niobate phase modulators at specific wavelengths and frequency specifications for Navy and research agency laboratories.

Customer concentration is diffuse across defense and civilian research agencies. The top five funding agencies by award count account for 62% of awards: the Navy Office of Naval Research leads with 63 awards ($12.1 million combined potential value), followed by the National Institute of Standards and Technology with 62 awards ($975 thousand), Navy Information Warfare Systems Command with 28 awards ($1.2 million), Naval Air Warfare Center with 24 awards ($11.4 million), and Army Materiel Command RDECOM with 15 awards ($7.6 million). The rankings by potential value diverge meaningfully — the Missile Defense Agency anchors the dollar distribution with 11 awards ($14.8 million), and the Defense Advanced Research Projects Agency contributes 6 awards ($14.2 million) — revealing that Eospace's large-dollar research contracts concentrate in strategic defense technology while smaller component orders spread across Navy laboratories and NIST. Total dollar exposure spans 27 distinct customer agencies.

Eospace sits on the Design, Development, Demonstration and Integration vehicle with 10 task orders; the source does not name additional IDIQs, GWACs, or BPAs. Activity has grown unevenly — four awards in 2022, twelve in 2023, seventeen in 2024, nine in 2025, and one as of early 2026 — reflecting SBIR and STTR award cycles. Eight awards (combined potential value $18.1 million) face ultimate completion within the next twenty-four months and therefore expose Eospace to recompete.

In its subcontract role (6% of awards), Eospace supplies RF mixers and phase modulators to L3Harris Technologies on Counter Communications Systems production work (five sub-awards between May 2024 and November 2025) and to Radiance Technologies on directed energy system integration lab and manufacturing-readiness work (seven sub-awards between May 2023 and September 2024). Eospace also provided modulators to Raytheon on the Birdseye Yonder and SUPERB surveillance-processing programs (three sub-awards between June 2023 and March 2024). These subcontract relationships anchor production and integration support for large-scale defense initiatives rather than research phases.

Eospace's award portfolio centers on optical instrument and lens manufacturing (100 awards, primary NAICS), research and development in physical and engineering sciences (37 and 34 awards respectively), and analytical laboratory instrument manufacturing (29 awards), with procurement split between laboratory equipment and supplies (83 PSC awards) and optical instruments, test equipment, and components (43 awards). Obligated spending stands at $63.8 million against combined potential value of $75.6 million (84% obligation rate), indicating steady execution and draw-down across the active contract base.